Cargando…

Studies on Interaction of Buffalo Brain Cystatin with Donepezil: An Alzheimer's Drug

When drugs bind to a protein, the intramolecular structures can be altered, resulting in conformational change of the protein. Donepezil, an Acetyl Cholinesterase inhibitor (AChE), is commonly prescribed to patients with Alzheimer's disease (AD) to enhance cholinergic neurotransmission. It is t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amin, Fakhra, Bano, Bilqees
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3767058/ https://www.ncbi.nlm.nih.gov/pubmed/24062965 http://dx.doi.org/10.1155/2013/842689

Ejemplares similares

Antidepressant Fluoxetine Modulates the In Vitro Inhibitory Activity of Buffalo Brain Cystatin: A Thermodynamic Study Using UV and Fluorescence Techniques
por: Amin, Fakhra, et al.
Publicado: (2014)

Cystatins in Health and Diseases
por: Shah, Aaliya, et al.
Publicado: (2008)

Journey of cystatins from being mere thiol protease inhibitors to at heart of many pathological conditions
por: Shamsi, Anas, et al.
Publicado: (2017)

Transdermal donepezil on the treatment of Alzheimer’s disease
por: Sozio, Piera, et al.
Publicado: (2012)

Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer’s drug candidates
por: Piemontese, Luca, et al.
Publicado: (2018)

Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases
por: Pooladgar, Parham, et al.
Publicado: (2022)

Diagnostic technique for myocardial infarction : based on plasma lipoproteins /
por: Bano, Bilqees
Publicado: (2004)

Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer’s Disease Patients in Japan: LIFE Study
por: Fukuda, Haruhisa, et al.
Publicado: (2022)

Donepezil in Alzheimer’s disease: From conventional trials to pharmacogenetics
por: Cacabelos, Ramón
Publicado: (2007)

Donepezil enhances understanding of degraded speech in Alzheimer's disease
por: Hardy, Chris J. D., et al.
Publicado: (2017)

Donepezil Treatment for Alzheimer's Disease in Chronic Dialysis Patients
por: Yiannopoulou, Konstantina G., et al.
Publicado: (2019)

Cystatin C in Alzheimer's disease
por: Kaur, Gurjinder, et al.
Publicado: (2012)

Donepezil Enhances Frontal Functional Connectivity in Alzheimer's Disease: A Pilot Study
por: Griffanti, Ludovica, et al.
Publicado: (2016)

Donepezil plus memantine versus donepezil alone for treatment of concomitant Alzheimer’s disease and chronic obstructive pulmonary disease: a retrospective observational study
por: Cao, Yangyi, et al.
Publicado: (2020)

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease
por: Chase, Thomas N., et al.
Publicado: (2017)

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
por: Farlow, Martin, et al.
Publicado: (2011)

Comparative Study of Donepezil-Loaded Formulations for the Treatment of Alzheimer’s Disease by Nasal Administration
por: Espinoza, Lupe Carolina, et al.
Publicado: (2022)

Brain-Targeted Polysorbate 80-Emulsified Donepezil Drug-Loaded Nanoparticles for Neuroprotection
por: Tao, Xiaojun, et al.
Publicado: (2021)

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
por: Unzeta, Mercedes, et al.
Publicado: (2016)

Effect of donepezil on transcranial magnetic stimulation parameters in Alzheimer's disease
por: Hwang, Yun Tae, et al.
Publicado: (2018)

Commentary: Donepezil enhances understanding of degraded speech in Alzheimer's disease
por: Campbell, Tom A., et al.
Publicado: (2018)

Donepezil, Anti-Alzheimer's Disease Drug, Prevents Cardiac Rupture during Acute Phase of Myocardial Infarction in Mice
por: Arikawa, Mikihiko, et al.
Publicado: (2011)

Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil
por: Ortner, Marion, et al.
Publicado: (2020)

Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer’s disease
por: Al Harthi, Sitah, et al.
Publicado: (2019)

Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer’s Disease in Rat Model
por: Shehata, Mustafa K, et al.
Publicado: (2023)

Donepezil and life expectancy in Alzheimer’s disease: A retrospective analysis in the Tajiri Project
por: Meguro, Kenichi, et al.
Publicado: (2014)

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer’s Disease
por: Waring, Jeffrey F., et al.
Publicado: (2015)

Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer’s disease
por: Junaid, Md., et al.
Publicado: (2019)

Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil
por: Tariot, Pierre N., et al.
Publicado: (2022)

Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia
por: Park, Kee Hyung, et al.
Publicado: (2021)

Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil
por: Espinoza, Lupe Carolina, et al.
Publicado: (2019)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
por: Zhang, Nan, et al.
Publicado: (2018)

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
por: Pachón-Angona, Irene, et al.
Publicado: (2019)

Donepezil improves vascular function in a mouse model of Alzheimer’s disease
por: Pellegrini, Carolina, et al.
Publicado: (2021)

Gintonin facilitates brain delivery of donepezil, a therapeutic drug for Alzheimer disease, through lysophosphatidic acid 1/3 and vascular endothelial growth factor receptors
por: Choi, Sun-Hye, et al.
Publicado: (2021)

Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil
por: Persson, Cecilia M, et al.
Publicado: (2009)

Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)
por: Knapp, Martin, et al.
Publicado: (2016)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease
por: Kagawa, Yoshiyuki, et al.
Publicado: (2021)

The Effect of Choline Acetyltransferase Genotype on Donepezil Treatment Response in Patients with Alzheimer’s Disease
por: Lee, Kang Uk, et al.
Publicado: (2015)

Effect of QT Prolongation in Patients Taking Cholinesterase Inhibitors (Donepezil) for Alzheimer’s Disease
por: Kuwahata, So, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_be914uafgr7p6uq6d5j8b67obi